Skip to contentSkip to navigation

Community engagement  —  1 minute

Montreal Clinical Research Institute (IRCM): Presentation of the Biron Groupe Santé fellowship

February 14th, 2024

On February 13, 2024, the Montreal Clinical Research Institute (IRCM) Foundation held its annual Recognition Ceremony. We are pleased to share with you that the Biron Groupe Santé 2023-2024 Fellowship was awarded to Ms. Ying Deng, a master’s student in the Research Unit in Regenerative Medicine for Diabetes, directed by Dr. Yasaman Aghazadeh.

Fellowship

This master's project is part of her team's innovative work within the research unit. Their objective is clear: to recreate human beta cells - cells found in the pancreatic islets that help regulate blood sugar levels - in the laboratory using stem cells capable of reproducing the different types of human cells. This promising approach aims to generate cellular therapies for type 1 diabetes (T1DM), via the transplantation and regeneration of pancreatic functions in T1DM patients [1].

This breakthrough is crucial in the search for solutions to diabetes. Currently, millions of people around the world depend on daily insulin injections to save their lives. If this method overcomes the current challenges, it could represent a promising avenue for a cure for T1DM.

Sources1
  1. Montreal Clinical Research Institute (2024). « Yasaman Aghazadeh, Director, Research Unit in Regenerative Medicine for Diabetes », https://www.ircm.qc.ca/en/researchers/yasaman-aghazadeh